Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
P2 Science Inc. currently manages 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 4 distinct examiners and 3 distinct art units. This distribution indicates that each examiner in the portfolio is currently handling a single pending action for the company. The presence of multiple distinct examiners for these actions means that prosecution strategies must be tailored to individual preferences rather than a centralized group.
CHANDRAKUMAR, NIZAL S is identified as the busiest examiner for this portfolio. This specific examiner is responsible for 1 pending office action. The parity between the total number of pending office actions and the number of distinct examiners suggests a fragmented prosecution landscape where no single examiner holds a majority of the workload. Practitioners should note that the filings are spread across 3 distinct art units. This variety in units implies that the Biotechnology & Pharmaceuticals filings for P2 Science Inc. cover diverse sub-specialties within the field.
The lack of examiner overlap prevents the use of consolidated arguments across the portfolio. Each action represents a unique interaction with the patent office. Because the pending office actions are in different art units, they are subject to different group-level policies. Practitioners must manage these matters as separate examiner interactions within the Biotechnology & Pharmaceuticals field. This requires navigating different individual perspectives within the technical groups.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHANDRAKUMAR, NIZAL S | 1 | 72.7% | +18.2% |
| BAHTA, MEDHANIT W | 1 | 80.6% | +27.8% |
| CUTLIFF, YATE KAI RENE | 1 | 79.8% | +24.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18703113 | SILYL ETHER DERIVATIVES OF POLYETHER POLYMERS | BAHTA, MEDHANIT W | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18550088 | THE OXIDATION OF CARBON-HYDROGEN BONDS USING OZONE | CUTLIFF, YATE KAI RENE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18867252 | IMPROVED SYNTHETIC METHODS FOR MAKING LACTONES | CHANDRAKUMAR, NIZAL S | 18d overdue |
| 18703113 | SILYL ETHER DERIVATIVES OF POLYETHER POLYMERS | BAHTA, MEDHANIT W | — |
| 18550088 | THE OXIDATION OF CARBON-HYDROGEN BONDS USING OZONE | CUTLIFF, YATE KAI RENE | — |
| Art Unit | Apps |
|---|---|
| 1692 | 2 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18867252 | IMPROVED SYNTHETIC METHODS FOR MAKING LACTONES | CHANDRAKUMAR, NIZAL S | 1625 | §112Other | Non-Final OA | 18d overdue | Pending | Nov 19, 2024 |
| 18703113 | SILYL ETHER DERIVATIVES OF POLYETHER POLYMERS | BAHTA, MEDHANIT W | 1692 | §112 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18550088 | THE OXIDATION OF CARBON-HYDROGEN BONDS USING OZONE | CUTLIFF, YATE KAI RENE | 1692 | §103§112 | Non-Final OA | — | Pending | Sep 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialP2 Science Inc. has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Nizal S Chandrakumar has the most, with 1 of P2 Science Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
